Guido van Amerongen

605 total citations
20 papers, 405 citations indexed

About

Guido van Amerongen is a scholar working on Physiology, Anesthesiology and Pain Medicine and Cognitive Neuroscience. According to data from OpenAlex, Guido van Amerongen has authored 20 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 5 papers in Anesthesiology and Pain Medicine and 4 papers in Cognitive Neuroscience. Recurrent topics in Guido van Amerongen's work include Pain Mechanisms and Treatments (11 papers), Veterinary Pharmacology and Anesthesia (3 papers) and Anesthesia and Sedative Agents (3 papers). Guido van Amerongen is often cited by papers focused on Pain Mechanisms and Treatments (11 papers), Veterinary Pharmacology and Anesthesia (3 papers) and Anesthesia and Sedative Agents (3 papers). Guido van Amerongen collaborates with scholars based in Netherlands, United States and United Kingdom. Guido van Amerongen's co-authors include Geert Jan Groeneveld, Justin L. Hay, Pieter Siebenga, Richard P. Butt, Marieke L. de Kam, Donal Gorman, Joop van Gerven, Erica S. Klaassen, Joop MA van Gerven and Rob Zuiker and has published in prestigious journals such as International Journal of Pharmaceutics, Experimental Brain Research and Psychopharmacology.

In The Last Decade

Guido van Amerongen

20 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido van Amerongen Netherlands 13 167 120 97 83 80 20 405
Jing Ping China 10 138 0.8× 73 0.6× 74 0.8× 55 0.7× 104 1.3× 37 446
Dewan Md. Sumsuzzman South Korea 13 190 1.1× 64 0.5× 55 0.6× 34 0.4× 113 1.4× 26 483
K. Schaffler United States 12 167 1.0× 83 0.7× 68 0.7× 65 0.8× 74 0.9× 51 415
Shima Kumei Japan 17 156 0.9× 32 0.3× 138 1.4× 32 0.4× 127 1.6× 38 570
Gloria Benson Germany 10 138 0.8× 120 1.0× 104 1.1× 26 0.3× 269 3.4× 21 559
Sonia Aroni Italy 10 82 0.5× 143 1.2× 48 0.5× 161 1.9× 102 1.3× 20 456
Hiroko Hori Japan 15 82 0.5× 21 0.2× 97 1.0× 136 1.6× 160 2.0× 29 538
Dongyu Hua China 12 143 0.9× 56 0.5× 35 0.4× 44 0.5× 187 2.3× 17 491
William Redmond Australia 9 173 1.0× 287 2.4× 172 1.8× 138 1.7× 94 1.2× 13 559
David Pache United Kingdom 12 107 0.6× 40 0.3× 60 0.6× 137 1.7× 102 1.3× 32 334

Countries citing papers authored by Guido van Amerongen

Since Specialization
Citations

This map shows the geographic impact of Guido van Amerongen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido van Amerongen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido van Amerongen more than expected).

Fields of papers citing papers by Guido van Amerongen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido van Amerongen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido van Amerongen. The network helps show where Guido van Amerongen may publish in the future.

Co-authorship network of co-authors of Guido van Amerongen

This figure shows the co-authorship network connecting the top 25 collaborators of Guido van Amerongen. A scholar is included among the top collaborators of Guido van Amerongen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido van Amerongen. Guido van Amerongen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kruithof, Annelieke C., Guido van Amerongen, Marieke L. de Kam, et al.. (2021). A randomized single and multiple ascending dose study in healthy volunteers of LTI‐291, a centrally penetrant glucocerebrosidase activator. British Journal of Clinical Pharmacology. 87(9). 3561–3573. 35 indexed citations
2.
Siebenga, Pieter, Guido van Amerongen, Justin L. Hay, et al.. (2019). Lack of Detection of the Analgesic Properties of PF‐05089771, a Selective Nav1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects. Clinical and Translational Science. 13(2). 318–324. 36 indexed citations
3.
Amerongen, Guido van, Pieter Siebenga, Rachel Gurrell, et al.. (2019). Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABAA partial agonist, in humans. British Journal of Anaesthesia. 123(2). e194–e203. 20 indexed citations
4.
5.
Siebenga, Pieter, Guido van Amerongen, William S. Denney, et al.. (2019). Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugs. European Journal of Pain. 23(6). 1129–1140. 11 indexed citations
6.
Amerongen, Guido van, Pieter Siebenga, Marieke L. de Kam, Justin L. Hay, & Geert Jan Groeneveld. (2018). Effect profile of paracetamol, Δ9‐THC and promethazine using an evoked pain test battery in healthy subjects. European Journal of Pain. 22(7). 1331–1342. 19 indexed citations
7.
Siebenga, Pieter, Guido van Amerongen, Erica S. Klaassen, et al.. (2018). The ultraviolet B inflammation model: Postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjects. European Journal of Pain. 23(5). 874–883. 12 indexed citations
8.
Amerongen, Guido van, Jules A. A. C. Heuberger, Erica S. Klaassen, et al.. (2017). Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis. Clinical Therapeutics. 40(9). 1467–1482. 59 indexed citations
9.
Loo, Aurora J.A.E. van de, Johan Garssen, Rob Zuiker, et al.. (2017). The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study. Psychopharmacology. 234(21). 3175–3183. 22 indexed citations
10.
Loudon, Peter T., Pieter Siebenga, Donal Gorman, et al.. (2017). Demonstration of an anti‐hyperalgesic effect of a novel pan‐Trk inhibitor PF‐06273340 in a battery of human evoked pain models. British Journal of Clinical Pharmacology. 84(2). 301–309. 18 indexed citations
11.
Amerongen, Guido van, Marieke L. de Kam, Jasper Stevens, et al.. (2016). The use of a battery of pain models to detect analgesic properties of compounds: a two‐part four‐way crossover study. British Journal of Clinical Pharmacology. 83(5). 976–990. 27 indexed citations
12.
Doll, Robert J., Guido van Amerongen, Justin L. Hay, et al.. (2016). Responsiveness of electrical nociceptive detection thresholds to capsaicin (8 %)-induced changes in nociceptive processing. Experimental Brain Research. 234(9). 2505–2514. 14 indexed citations
13.
Hay, Justin L., et al.. (2016). Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery. Journal of Visualized Experiments. 16 indexed citations
14.
Hay, Justin L., et al.. (2016). Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery. Journal of Visualized Experiments. 5 indexed citations
15.
Brooks, Stephen N., Justine Kent, Gabriël E. Jacobs, et al.. (2016). The orexin-2 antagonist JNJ-42847922 (MIN-202) improves sleep in patients with major depressive disorder (MDD) suffering from comorbid insomnia. European Neuropsychopharmacology. 26. S408–S409. 1 indexed citations
16.
Amerongen, Guido van, et al.. (2016). A literature review on the pharmacological sensitivity of human evoked hyperalgesia pain models. British Journal of Clinical Pharmacology. 82(4). 903–922. 34 indexed citations
17.
18.
Grainger, C., et al.. (2003). Administration of an insulin powder to the lungs of cynomolgus monkeys using a Penn Century insufflator. International Journal of Pharmaceutics. 269(2). 523–527. 16 indexed citations
19.
Guillon, Laurent, et al.. (1997). Fibrinogen Poissy I: a new case of the A alpha Arg 16His fibrinogen variant.. PubMed. 8(7). 441–4. 3 indexed citations
20.
Schutten, Martin, et al.. (1997). Pharmacokinetics of succinylated serum albumin in mice, rats and monkeys: Implications for dosage regimens in the therapy of HIV-infection and anti-HIV efficacy in mice. Data Archiving and Networked Services (DANS). 103–104. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jing Ping Breakdown of academic impact, for papers by Dewan Md. Sumsuzzman Breakdown of academic impact, for papers by K. Schaffler Breakdown of academic impact, for papers by Shima Kumei Breakdown of academic impact, for papers by Gloria Benson Breakdown of academic impact, for papers by Sonia Aroni Breakdown of academic impact, for papers by Hiroko Hori Breakdown of academic impact, for papers by Dongyu Hua Breakdown of academic impact, for papers by William Redmond Breakdown of academic impact, for papers by David Pache
Rankless by CCL
2026